Hippo-YAP/TAZ signaling in gastric cancer: orchestrating epithelial-stromal heterogeneity, plasticity, and therapy resistance
Cancer Heterogeneity and Plasticity · 02.07.2026
DOI: 10.47248/chp2603030008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Heterogeneity and Plasticity, online erschienen am 02.07.2026. Verfasst von Junsong Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Coriell Institute for Medical Research, 403 Haddon Ave, Camden, NJ 08103, USA. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Gastric cancer is a lethal malignancy with highly variable clinical behavior, reflecting both inter-tumor diversity and marked heterogeneity within individual lesions. Large-scale genomics data (including TCGA and ACRG) has delineated recurring molecular subtypes, while expression- and immunohistochemistry-based schemes provide clinically practical surrogates. However, single-cell and spatial profiling reveal that most tumors comprise multiple malignant epithelial states alongside diverse cancer-associated fibroblast (CAF) and immune programs that vary spatially, evolve during progression, and are remodeled by therapy. The Hippo pathway effectors YAP and TAZ act as central integrators of oncogenic, inflammatory, and mechanical cues that coordinate these dynamic states. In gastric cancer, YAP/TAZ activity is enriched in diffuse/EMT-like and mesenchymal phenotypes, associates with peritoneal dissemination, and contributes to immune evasion and treatment resistance. Here, we link YAP/TAZ activity to gastric cancer subtype heterogeneity and emphasize two interconnected dimensions: (i) cell heterogeneity, encompassing coexisting epithelial lineage states and CAF subsets within tumors; and (ii) cell plasticity, highlighting reversible transitions that enable invasion, metastasis, and drug resistance. Finally, we propose a framework of YAP/TAZ-governed epithelial-stromal ecotypes and discuss implications for biomarkers and rational combination strategies incorporating Hippo-targeted agents with chemotherapy, stromal modulation, and immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Coriell Institute for Medical Research, 403 Haddon Ave, Camden, NJ 08103, USA.
- Camden Cancer Research Center, 403 Haddon Ave, Camden, NJ 08103, USA.
- Departments of Biomedical Sciences, Cooper Medical School of Rowan University, 401 Broadway, Camden, NJ 08103, USA.
- MD Anderson Cancer Center at Cooper, Cooper University Hospital, 2 Cooper Plaza, Camden, NJ 08103, USA.
- Department of Surgery, Cooper University Hospital, 3 Cooper Plaza, Camden, NJ 08103, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Zhao, J., Balch, C., Athavale, D., Zhang, Y., Yao, X., Ghelfi, M., Torres, M. B., Hong, Y. K., Morrison, J., Spitz, F., Grana, G., & Song, S. (2026). Hippo-YAP/TAZ signaling in gastric cancer: orchestrating epithelial-stromal heterogeneity, plasticity, and therapy resistance. Cancer Heterogeneity and Plasticity. https://doi.org/10.47248/chp2603030008
Vancouver
Zhao J, Balch C, Athavale D, Zhang Y, Yao X, Ghelfi M, et al. Hippo-YAP/TAZ signaling in gastric cancer: orchestrating epithelial-stromal heterogeneity, plasticity, and therapy resistance. Cancer Heterogeneity and Plasticity. 2026. doi:10.47248/chp2603030008
BibTeX
@article{Zhao2026,
author = {Zhao, Junsong and Balch, Curt and Athavale, Dipti and Zhang, Yanting and Yao, Xiaodan and Ghelfi, Mikel and Torres, Madeline B and Hong, Young Ki and Morrison, Jamin and Spitz, Francis and Grana, Generosa and Song, Shumei},
title = {Hippo-YAP/TAZ signaling in gastric cancer: orchestrating epithelial-stromal heterogeneity, plasticity, and therapy resistance},
journal = {Cancer Heterogeneity and Plasticity},
year = {2026},
doi = {10.47248/chp2603030008}
}
EUVIMED